ALOX5 and systemic sclerosis: Later, researchers have also proved that gene polymorphism of 5-LOX activating protein is related to increased risk of ILD in SSc patients (Kowal-Bielecka et al., 2017a), which leads to the conclusion that leukotriene metabolism is also deeply dysregulated in SSc.